Search This Blog

Tuesday, March 31, 2026

Lilly to acquire Centessa Pharmaceuticals for $38.00 per share in cash plus CVR

 

Eli Lilly to acquire Centessa Pharmaceuticals for $38.00 per share in cash plus CVR up to $9.00

  • Non-transferable CVR could lift total deal value to $47.00 per share if milestones are achieved.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)